Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Nov 2023 for Intercept Pharmaceuticals, INC., €192k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Rocco Venezia: trading record in brief
Rocco Venezia is a declared insider of Intercept Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). We count 9 filings; the first trade dates from 1 July 2021 and the latest from 8 November 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 13 November 2023, the filings show a transaction worth €192k in Intercept Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rocco Venezia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
10,782 shares@ US$19.0080.8% of flowCommon StockSEC:0001104659-23-117117:0
9,800 shares0Common StockSEC:0001104659-23-008594:0
675 shares@ US$12.373.3% of flowCommon StockSEC:0001104659-23-000338:0
429 shares@ US$18.063.3% of flowCommon StockSEC:0001104659-22-097846:0
3,600 shares0Common StockSEC:0001104659-22-009565:0
515 shares@ US$16.293.3% of flowCommon StockSEC:0001104659-22-000925:0
30 shares@ US$15.220.2% of flowCommon StockSEC:0001104659-21-123212:0
524 shares@ US$15.053.0% of flowCommon StockSEC:0001104659-21-113044:0
30 shares@ US$20.470.2% of flowCommon StockSEC:0001104659-21-089033:0
9 of 9 declarations
